Concepedia

Bioequivalence of generic and branded subcutaneous enoxaparin: A single-dose, randomized-sequence, open-label, two-period crossover study in healthy Chinese male subjects

Limin Feng, Jianzhong Shentu, Jian Liu, Junchun Chen, Lihua Wu, Mingzhu Huang

Clinical Therapeutics · 2009 · 25 citations · 15 references

DOI

Concepts

References

15

Physicians Desk Reference

Ronald A. Arky · 1994 · 2.6K citations

, , +11

The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison

David G. Sherman, Gregory W. Albers, Christopher Bladin et al. · The Lancet · 2007 · 332 citations

, , +16

Assay of heparin in plasma using a chromogenic substrate for activated factor X

Arne N. Teien, M. Lie, Ulrich Abildgaard · Thrombosis Research · 1976 · 297 citations

, , +6

The pharmacokinetics and pharmacodynamics of enoxaparin in obese volunteers

Ger‐Jan Sanderink, A. Le Liboux, Navin Jariwala et al. · Clinical Pharmacology & Therapeutics · 2002 · 184 citations · Full text

, , +13

Comparison of the Pharmacokinetic Profiles of Three Low Molecular Mass Heparins – Dalteparin, Enoxaparin and Nadroparin – Administered Subcutaneously in Healthy Volunteers (Doses for Prevention of Thromboembolism)

F. Collignon, Armand Frydman, Henri Caplain et al. · Thrombosis and Haemostasis · 1995 · 178 citations

, , +17